The Latin America, Middle East and Africa Fertility Supplements Market should witness market growth of 10.3% CAGR during the forecast period (2022-2028).
The number of antioxidants in the fluid surrounding the egg diminishes as women age. The cells that surround the egg are much less able to nourish it without antioxidant defense. Reduced embryo viability and conception chances are related to those cells' poor function as a result. Oxidation products are associated with low semen quality, decreased sperm motility, and sperm DNA fragmentation in males. Both sexes can consume fertility supplements with more antioxidants to lessen the harmful effects of oxidation.
By aiding in the restoration of micronutrients, vitamins, and minerals to recommended levels and bolstering the antioxidant defense system, fertility supplementation can improve the reproductive environment. This will alleviate oxidative stress and have the clinical advantages of improving embryo and oocyte quality, speeding up the process of becoming pregnant, and increasing the likelihood of conception. The use of fertility supplements may be a wise course of action for both healthy women who are attempting to conceive and those who are experiencing reproductive issues.
Expansion is being fueled by consumers' expanding interest for infertility prevention strategies including eating a balanced diet and using more nutritional supplements. In addition, a number of ailments, including sexually transmitted infections (STDs) and conditions that impact fertility, are responsible for the increase in infertility rates. Recently, Argentine and Brazilian consumers have placed a strong emphasis on improving their well-being and sexual health. Preterm birth has increased everywhere, but particularly in Brazil.
The Brazil market dominated the LAMEA Fertility Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.2 million by 2028. The Argentina market is anticipated to grow at a CAGR of 10.9% during (2022-2028). Additionally, The UAE market would exhibit a CAGR of 10% during (2022-2028).
Based on Ingredient, the market is segmented into Synthetic/ Blend of Natural & Synthetic and Natural. Based on End-Use, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Over-the-counter and Prescribed. Based on Product, the market is segmented into Capsules, Tablets, Soft Gels, Powder, and Liquid. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Fairhaven Health, Coast Science LLC, LENUS Pharma GesmbH, CellOxess LLC, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc. (Grupo INSUD), Yad-Tech, Bionova Lifesciences (Pragati Biocare Pvt. Ltd.), Vitabiotics Ltd., and TTK Healthcare Limited.
The number of antioxidants in the fluid surrounding the egg diminishes as women age. The cells that surround the egg are much less able to nourish it without antioxidant defense. Reduced embryo viability and conception chances are related to those cells' poor function as a result. Oxidation products are associated with low semen quality, decreased sperm motility, and sperm DNA fragmentation in males. Both sexes can consume fertility supplements with more antioxidants to lessen the harmful effects of oxidation.
By aiding in the restoration of micronutrients, vitamins, and minerals to recommended levels and bolstering the antioxidant defense system, fertility supplementation can improve the reproductive environment. This will alleviate oxidative stress and have the clinical advantages of improving embryo and oocyte quality, speeding up the process of becoming pregnant, and increasing the likelihood of conception. The use of fertility supplements may be a wise course of action for both healthy women who are attempting to conceive and those who are experiencing reproductive issues.
Expansion is being fueled by consumers' expanding interest for infertility prevention strategies including eating a balanced diet and using more nutritional supplements. In addition, a number of ailments, including sexually transmitted infections (STDs) and conditions that impact fertility, are responsible for the increase in infertility rates. Recently, Argentine and Brazilian consumers have placed a strong emphasis on improving their well-being and sexual health. Preterm birth has increased everywhere, but particularly in Brazil.
The Brazil market dominated the LAMEA Fertility Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.2 million by 2028. The Argentina market is anticipated to grow at a CAGR of 10.9% during (2022-2028). Additionally, The UAE market would exhibit a CAGR of 10% during (2022-2028).
Based on Ingredient, the market is segmented into Synthetic/ Blend of Natural & Synthetic and Natural. Based on End-Use, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Over-the-counter and Prescribed. Based on Product, the market is segmented into Capsules, Tablets, Soft Gels, Powder, and Liquid. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Fairhaven Health, Coast Science LLC, LENUS Pharma GesmbH, CellOxess LLC, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc. (Grupo INSUD), Yad-Tech, Bionova Lifesciences (Pragati Biocare Pvt. Ltd.), Vitabiotics Ltd., and TTK Healthcare Limited.
Scope of the Study
By Ingredient
- Synthetic/ Blend of Natural & Synthetic
- Natural
By End-use
- Women
- Men
By Distribution Channel
- Over-the-counter
- Prescribed
By Product
- Capsules
- Tablets
- Soft Gels
- Powder
- Liquid
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Fairhaven Health
- Coast Science LLC
- LENUS Pharma GesmbH
- CellOxess LLC
- Orthomol pharmazeutische Vertriebs GmbH
- Exeltis USA, Inc. (Grupo INSUD)
- Yad-Tech
- Bionova Lifesciences (Pragati Biocare Pvt. Ltd.)
- Vitabiotics Ltd.
- TTK Healthcare Limited
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Fertility Supplements Market by Ingredient
Chapter 4. LAMEA Fertility Supplements Market by End-use
Chapter 5. LAMEA Fertility Supplements Market by Distribution Channel
Chapter 6. LAMEA Fertility Supplements Market by Product
Chapter 7. LAMEA Fertility Supplements Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Fairhaven Health
- Coast Science LLC
- LENUS Pharma GesmbH
- CellOxess LLC
- Orthomol pharmazeutische Vertriebs GmbH
- Exeltis USA, Inc. (Grupo INSUD)
- Yad-Tech
- Bionova Lifesciences (Pragati Biocare Pvt. Ltd.)
- Vitabiotics Ltd.
- TTK Healthcare Limited
Methodology
LOADING...
